Inside the RadPartners-MEDNAX Fusion: What's To Come
Diagnostic Imaging spoke with Radiology Partners Chairman and CEO Rich Whitney, Associate CMO Nina Kottler, M.D., and MEDNAX Radiology Solutions CMO Ricardo Cury, M.D., about this newly finalized partnership, what it means for the companies, and how it could impact the industry.
On Dec. 16, Radiology Partners and MEDNAX Radiology Solutions announced the completion of their partnership – a deal that has been valued at $885 million.
This agreement fuses MEDNAX’s more than 800 radiologists with the 1,600 providers who currently work for Radiology Partners. More than 300 of MEDNAX’s providers currently work onsite in several states, and 500 more are teleradiologists.
Across the industry, this partnership is expected to open doors for larger clinical programs and significant levels of innovation. Diagnostic Imaging sat down with MEDNAX chief medical officer Ricardo Cury, M.D., as well as Radiology Partners chairman and chief executive officer Rich Whitney and associate chief medical officer Nina Kottler, M.D., to talk about why this merger is a good fit, what new capabilities it introduces, and what it could mean for radiology as a whole.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
